Patents by Inventor Kye-Seong Kim

Kye-Seong Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220380724
    Abstract: The present invention relates to: a composition for promoting the proliferation of pluripotent stem cells, containing, as an active ingredient, cP1P or a pharmaceutically acceptable salt thereof; and a composition added to a stem cell culture liquid. When culturing stem cells by using a composition for promoting the proliferation of stem cells and a composition added to a stem cell culture medium, according to the present invention, sternness can be strengthened, growth can be promoted, and apoptosis can be inhibited.
    Type: Application
    Filed: January 21, 2020
    Publication date: December 1, 2022
    Applicants: INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY, AXCESO BIOPHARMA CO., LTD.
    Inventors: Kye Seong KIM, Jung Jin LIM, Hyung Joon KIM, Myeong Jun CHOI, Su Jin KIM
  • Patent number: 7674617
    Abstract: The present invention relates to novel miRNA molecules, more particularly to novel miRNA molecules isolated from human embryonic stem cells. The miRNA molecules provided by the present invention can be usefully used as a molecular marker for early developmental stages of undifferentiated human embryonic stem cells. Also, the miRNA molecules of the present invention may play an important role in the regulation of mammalian embryonic stem cells. Therefore, the miRNA molecules can be usefully used for analyzing regulatory networks of human embryonic stem cells.
    Type: Grant
    Filed: December 15, 2004
    Date of Patent: March 9, 2010
    Assignee: College of Medicine, Pochon Cha University Industry -Academic Cooperation Foundation
    Inventors: Kye-Seong Kim, Mi-Ra Suh, Vit-Narry Kim
  • Publication number: 20080050722
    Abstract: The present invention relates to novel miRNA molecules, more particularly to novel miRNA molecules isolated from human embryonic stem cells. The miRNA molecules provided by the present invention can be usefully used as a molecular marker for early developmental stages of undifferentiated human embryonic stem cells. Also, the miRNA molecules of the present invention may play an important role in the regulation of mammalian embryonic stem cells. Therefore, the miRNA molecules can be usefully used for analyzing regulatory networks of human embryonic stem cells.
    Type: Application
    Filed: December 15, 2004
    Publication date: February 28, 2008
    Applicant: Kye-Seong Kim
    Inventors: Kye-Seong Kim, Mi-Ra Suh, Vit-Narry Kim
  • Publication number: 20080044395
    Abstract: The present invention discloses methods for isolating, proliferating and differentiating germ-line stem cell in vitro. More specifically, the present invention discloses a method for the in vitro isolation and proliferation of mammalian germ-line stem cells, characterized in culturing cells isolated from mammalian testis in an embryonic stem cell culture medium, and for the in vitro differentiation, characterized in encapsulating mammalian germ-line stem cells and Sertoli cells with calcium alginate and co-culturing with peritubular cells. Also, the present invention discloses germ-line stem cells obtained by above methods, a composition for the treatment of male infertility, comprising the germ-line stem cells, and a method for the treatment of male infertility by the use of the germ-line stem cells.
    Type: Application
    Filed: April 13, 2004
    Publication date: February 21, 2008
    Applicants: SUNGKWANG EDUCATIONAL FOUNDATION, CHABIOTECH CO., LTD.
    Inventors: Kye-Seong Kim, Dong-Ryul Lee